A person familiar with the matter revealed that the Chinese government considers the vaccination of the fourth shot of the coronary vaccine as soon as possible.Facing the most widely spread epidemic since the emergence of crown disease, China ’s epidemic prevention policy marked by“ dynamic clearance ”has also undergone increasing pressure.

Bloomberg quoted people who are unwilling to be named, saying that plans related to the fourth vaccination of the crown vaccine are currently being formulated, and the specific launch time and related details have not yet been finalized.

One of the people familiar with the matter said that if the vaccine production cannot fully meet the needs in time, it will give priority to the qualified elderly group inoculation.

The China State Council ’s joint defense and control mechanism issued a notice on Tuesday (November 29) on strengthening the vaccination work plan for the elderly.Crossing rate.

According to the data disclosed at the press conference that afternoon of the afternoon of Xia Gang of the State CDC, as of November 28, 86.4 % of the elderly over the age of 60 in China completed the full vaccination throughout the process.(Two stitches or one -pin adenovirus vector vaccine), 68.7 % complete the enhanced immunization (one dose of additional agent); the total vaccination rate of elderly people over 80 years old is 65.8 %; the enhanced immune vaccination rate is only 40.4%.

Researcher Chang Zhaorui, a researcher at the China Centers for Disease Control and Prevention, acknowledged at the press conference that the pathogen and poisoning of Omikon's mutant strains and its evolutionThe strain was obviously weakened, and the proportion of severe illness and death was significantly reduced.

But Chang Zhaorui also emphasized that after the infection of the Basic disease, age, and people who have not vaccinated Vaccine, a certain proportion may still be severe.

According to another report, a new survey released by China's brown book shows that the new type of coronary virus is rapidly spreading in China, and production activities are further affected. Among the companies that are investigated, more than half of Chinese companies are Chinese companies.Employees confirmed the crown disease this month, the highest level since January last year.